EU External Trade - PRODUCTS OF ANIMAL ORIGIN, NOT ELSEWHERE SPECIFIED OR INCLUDED, Ambergris, castoreum, civet and musk; cantharides; bile, whether or not dried; glands and other animal products used in the preparation of pharmaceutical products, fresh, chilled, frozen or otherwise provisionally preserved

Extra-EU sourcing of PRODUCTS OF ANIMAL ORIGIN, NOT ELSEWHERE SPECIFIED OR INCLUDED, Ambergris, castoreum, civet and musk; cantharides; bile, whether or not dried; glands and other animal products used in the preparation of pharmaceutical products, fresh, chilled, frozen or otherwise provisionally preserved is highly concentrated. 🇺🇸 United States captures 41.5% of imports (€50.1M), followed by 🇨🇱 Chile (24.5%). With an HHI of 2662, this Concentrated market exposes the EU to supply dependency risks.

The main extra-EU export markets for PRODUCTS OF ANIMAL ORIGIN, NOT ELSEWHERE SPECIFIED OR INCLUDED, Ambergris, castoreum, civet and musk; cantharides; bile, whether or not dried; glands and other animal products used in the preparation of pharmaceutical products, fresh, chilled, frozen or otherwise provisionally preserved are 🇺🇸 United States, 🇧🇷 Brazil, 🇨🇦 Canada. 🇺🇸 United States absorbs 31.1% of European exports (€29.0M).

Within the EU, the leading importers of PRODUCTS OF ANIMAL ORIGIN, NOT ELSEWHERE SPECIFIED OR INCLUDED, Ambergris, castoreum, civet and musk; cantharides; bile, whether or not dried; glands and other animal products used in the preparation of pharmaceutical products, fresh, chilled, frozen or otherwise provisionally preserved are 🇩🇪 Germany, 🇩🇰 Denmark, 🇳🇱 Netherlands. 🇩🇪 Germany accounts for 35.1% of EU imports.

In 2025, imports were stable (-0.2%) and exports declining (-14.4%) compared to the previous year.